Overview

• Specialists report growing diagnoses in people who never smoked and in patients as young as 30–45.
• Environmental exposures such as wood-smoke cooking, urban air pollution, asbestos and unmeasured radon are cited as risks, while tobacco still accounts for roughly 85 percent of cases.
• Globocan data show more than 8,200 new cases and over 7,800 deaths in Mexico in 2022, with about 82 percent detected late.
• Cofepris has approved amivantamab plus lazertinib for EGFR-mutated advanced non-small cell lung cancer after the MARIPOSA trial showed improved overall survival and fewer new brain metastases.
• Oncologists urge early-detection policies, reliable national registries, and wider access to molecular testing and modern treatments.